Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2, Update Alert 3)

Authors
Qaseem, Amir
Yost, Jennifer
Etxeandia-Ikobaltzeta, Itziar
Abraham, George
Jokela, Janet A.
Forciea, Mary Ann
Miller, Matthew C.
Humphrey, Linda L.
UMass Chan Affiliations
Department of Medicine
Document Type
Journal Article
Publication Date
2022-03-01
Keywords
remdesivir
COVID-19
Health Services Administration
Health Services Research
Infectious Disease
Therapeutics
Virus Diseases

Metadata
Show full item record
Link to Full Text
https://doi.org/10.7326/m21-4810
Abstract
This is an update of the American College of Physicians' living, rapid practice points on the use of remdesivir for treatment of COVID-19. This update is based on an updated living, rapid systematic review that included studies published through 19 October 2021 and identified 2 new studies meeting inclusion criteria.
Source

Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Abraham GM, Jokela JA, Forciea MA, Miller MC, Humphrey LL; Scientific Medical Policy Committee of the American College of Physicians*. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2, Update Alert 3). Ann Intern Med. 2022 Mar 1. doi: 10.7326/M21-4810. Epub ahead of print. PMID: 35226518. Link to article on publisher's site
DOI
10.7326/M21-4810
Permanent Link to this Item
http://hdl.handle.net/20.500.14038/27546
PubMed ID
35226518
Related Resources

Link to Article in PubMed
Collections